NaturalVue studies assess myopia management efficacy

Visioneering Technologies Inc (VTI) has shared the results of three independent studies that assessed myopic children wearing its NaturalVue multifocal one day contact lenses.

The company said the findings combined with six-year data published in 2022, suggested the contact lens effectively managed eye growth and refractive error change over two years of follow-up at least.

Dr Ashley Tuan, VTI’s chief medical officer, said: ‘Despite having vastly different demographics with sites spread across America, the results in these three studies were remarkably similar. This demonstrates that real-world results with this unique design are consistent and repeatable.’